CuriRx launches Advanced Bioprocessing and Analytical Center

By The Science Advisory Board staff writers

January 27, 2022 -- CuriRx has launched its Advanced Bioprocessing and Analytical Center to provide end-to-end support to the developers of biotherapeutics.

The center offers developers the ability to accelerate biotherapeutic drug development and overcome challenges by leveraging CuriRx's bioprocessing experience, its CuriLytics platform, and the latest methods in upstream and downstream process development, according to CuriRx.

CuriRx is a contract development and manufacturing organization that offers upstream and downstream process development, optimization, characterization, scale-up and scale down, analytical development, formulation development, and lyophilization services.

Copyright © 2022

Create an Account

Already have an account? Sign in Here

To access all ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for

Email Preferences

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.